Impact of coronavirus infection on cognitive functions in elderly patients
- Authors: Potupchik T.V1, Evert L.S2, Kostyuchenko Y.R2
-
Affiliations:
- V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia
- Research Institute for Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences
- Issue: Vol 32, No 6 (2021)
- Pages: 41-50
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/114440
- DOI: https://doi.org/10.29296/25877305-2021-06-08
- ID: 114440
Cite item
Abstract
The paper reviews information on the etiology and pathogenesis of neurological manifestations in patients who have had coronavirus infection (COVID-19). It presents the data of studies that have shown that cognitive impairment is the long-term consequences of the central nervous system. Elderly patients are more susceptible to neuropsychiatric and cognitive impairment in COVID-19, and in the case of pre-existing cognitive impairment and dementia after a coronavirus infection; they are observed to have a progression of these disorders. Early detection of neuropsychological manifestations in persons who have experienced COVID-19 can lower the risk of subsequent irreversible disorders and further neurocognitive decline. Nootropic, metabolic, and antioxidant agents with a neuroprotective effect can be recommended for correction of cognitive impairment in elderly patients.
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
T. V Potupchik
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia
Email: potupchik_tatyana@mail.ru
L. S Evert
Research Institute for Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences
Yu. R Kostyuchenko
Research Institute for Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences
References
- Бездетко Н.В. Цитиколин: новое об известном. Международный неврологический журнал. 2015; 4: 90-4
- Веселова О.Ф., Крысенко Л.В., Макарова М.В. и др. Вопросы современной науки: монография. М.: Интернаука, 2017; 22.
- Государственный реестр лекарственных средств [Электронный ресурс]. URL: https://grls.rosminzdrav.ru/grls.aspx
- Громова О.А., Торшин И.Ю., Стаховская Л.В. и др. Опыт применения мексидола в неврологической практике. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018; 118 (10): 97-107 DOI. 10.17116/jnevro201811810197
- Камчатнов П.Р. Коррекция когнитивных и эмоциональных расстройств у больных артериальной гипертонией. Русский медицинский журнал. 2019; 7: 28-9
- Краснов В.С. Актовегин в терапии когнитивных нарушений у пациентов, перенесших новую коронавирусную инфекцию COVID-19 (опыт клинических наблюдений). Эффективная фармакотерапия. 2021; 17 (6): 8-12 doi: 10.33978/2307-3586-2021-17-6-8-12
- Кудлай Д.А., Широбоков Я.Е., Гладунова Е.П. и др. Диагностика COVID 19. Способы и проблемы обнаружения вируса SARSCoV-2 в условиях пандемии. Врач. 2020; 31 (8): 5-10. doi: 10.29296/25877305-2020-08-01
- Мазин П.В., Шешунов И.В., Мазина Н.К. Метааналитическая оценка клинической эффективности цитофлавина при неврологических заболеваниях. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017; 117 (3): 28-39 DOI. 10.17116/ jnevro20171173128-39
- Пизова Н.В., Пизов Н.А., Пизов А.В. Когнитивные нарушения у лиц, перенесших COVID-19. Медицинский совет. 2021; 4: 69-77 doi: 10.21518/2079-701X-2021-4-69-77
- Потупчик Т.В., Веселова О.Ф., Эверт Л.С. Фармакодинамические аспекты применения некоторых ноотропных средств при когнитивных нарушениях. Фарматека. 2014; 13: 90-5
- Чуканова Е.И., Чуканова А.С. Холина альфосцерат (делецит) как одно из направлений лечения когнитивных расстройств. Медицинский алфавит. 2016; 14: 12-6
- Almeria M., Cejudo J.C., Sotoca J. et al. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health. 2020; 9: 100163. DOI: 10.1016/j. bbih.2020.100163
- Alonso-Lana S., Marquie M., Ruiz A. et al. Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia. Front Aging Neurosci. 2020; 12: 588872. doi: 10.3389/fnagi.2020.588872
- Annweiler C., Bourgeais A., Faucon E. et al. Neurological, Cognitive, and Behavioral Disorders during COVID-19: The Nitric Oxide Track. J. Am Geriatr Soc. 2020; 68 (9): 1922-3. doi: 10.1111/jgs.16671
- Beaud V., Crottaz-Herbette S., Dunet V. et al. Pattern of cognitive deficits in severe COVID-19. J. Neurol Neurosurg Psychiatry. 2021; 92 (5): 567-8. doi: 10.1136/jnnp-2020-325173
- Delorme C., Paccoud O., Kas A. et al. COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. CoCo-Neurosciences study group and COVID SMIT PSL study group. Eur J. Neurol. 2020; 27 (12): 2651-7. doi: 10.1111/ene.14478
- El H.M., Altintas E., Chapelet G. et al. High depression and anxiety in people with Alzheimer’s disease living in retirement homes during the COVID-19 crisis. Psychiatry Res. 2020; 291: 113294. doi: 10.1016/j.psychres.2020.113294
- Helms J., Kremer S., Merdji H. et al. Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients. Crit Care. 2020; 24 (1): 491. doi: 10.1186/s13054-020-03200-1
- Heneka M.T., Golenbock D., Latz E. et al. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020; 12 (1): 69. doi: 10.1186/s13195-020-00640-3
- Malkova A., Kudlay D., Kudryavtsev I. et al. Immunogenetic Predictors of Severe COVID-19. Vaccines. 2021; 9: 211. doi: 10.3390/vaccines9030211
- Miners S., Kehoe P.G., Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res Ther. 2020; 12 (1): 170. DOI: 10.1186/ s13195-020-00744-w
- Negrini F., Ferrario I., Mazziotti D. et al. Neuropsychological Features of Severe Hospitalized Coronavirus Disease 2019 Patients at Clinical Stability and Clues for Postacute Rehabilitation. Arch Phys Med Rehabil. 2021; 102 (1): 155-8. doi: 10.1016/j.apmr.2020.09.376
- Riordan P., Stika M., Goldberg J. et al. COVID-19 and clinical neuropsychology: A review of neuropsychological literature on acute and chronic pulmonary disease. Clin Neuropsychol. 2020; 34 (7-8): 1480-97. doi: 10.1080/13854046.2020.1810325
- Sepilveda-Loyola W., Rodriguez-Sanchez I., Perez-Rodriguez P. et al. Impact of Social Isolation Due to COVID-19 on Health in Older People: Mental and Physical Effects and Recommendations. J. Nutr Health Aging. 2020; 24 (9): 938-47. doi: 10.1007/s12603-020-1469-2
- Serrano-Castro P.J., Estivill-Torris G., Cabezudo-Garcia P. et al. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? Neurologia. 2020; 35 (4): 245-51. DOI: 10.1016/j. nrl.2020.04.002
- Soltani Z.H., Gorji A., Ghadiri T.A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View. Mol Neurobiol. 2021; 58 (2): 536-49. doi: 10.1007/s12035-020-02149-0
- Stefano G.B., Ptacek R., Ptackova H. et al. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce ‘Brain Fog’ and Results in Behavioral Changes that Favor Viral Survival. Med Sci Monit. 2021; 27: e930886. doi: 10.12659/MSM.930886
- Varatharaj A., Thomas N., Ellul M.A. et al. CoroNerve Study Group. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020; 7 (10): 875-82. doi: 10.1016/S2215-0366(20)30287-X
- Xiong J., Lipsitz O., Nasri F. et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J. Affect Disord. 2020; 277: 55-64. doi: 10.1016/j.jad.2020.08.001
- Zhou H., Lu S., Chen J., et al. The landscape of cognitive function in recovered COVID-19 patients. JPsychiatrRes. 2020; 129: 98-102. DOI: 10.1016/j. jpsychires.2020.06.022
- Zhou J., Liu C., Sun Y. et al. Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study. Brain Behav Immun. 2021; 91: 383-92. doi: 10.1016/j.bbi.2020.10.019
Supplementary files
![](/img/style/loading.gif)